placeholder image
A. A. Ciesla All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis. 
    Lancet Reg Health Am. 2025
  • Estimated 2023-2024 COVID-19 vaccine effectiveness in adults. 
    JAMA network open. 2025
  • Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. 
    Lancet (London, England). 2024
  • Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design. 
    Vaccine. 2023
    • Contact
    full name
  • A. A. Ciesla
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration